On standalone basis, the company's net profit was almost flat at Rs 267.35 crore while the net sales rose 14.5% to Rs 1139.92 crore. The result was announced on Saturday, 10 August 2019.
Meanwhile, the S&P BSE Sensex was up 17 points or 0.04% to 37598.47.
On BSE, 57000 shares were traded in Divi's Laboratories counter, compared to a 2-week average of 15000 shares. The stock hit a high of Rs 1649 and a low of Rs 1512.1 so far during the day. The stock hit a 52-week high of Rs 1769 on 2 May 2019 and hit a 52-week low of Rs 1079.8 on 14 August 2018.
Divi's Laboratories is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and intermediates.